Tests to detect the presence and activity of hepatitis B virus (HBV) are the cornerstones of
diagnosis and management. Assays that detect or measure serum levels of HB surface …

Around 257 million people worldwide have chronic hepatitis B virus (HBV) infection, which
leads to almost 1 million deaths per year from complications, mainly decompensated …

Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …

Background & Aims It has been proposed that serum hepatitis B core-related antigen
(HBcrAg) reflects intrahepatic covalently closed circular (ccc) DNA levels. However, the …

Hepatitis B core-related antigen (HBcrAg) has been suggested as an additional marker of
hepatitis B virus (HBV) infection. HBcrAg combines the antigenic reactivity resulting from …

Background Little is known about stopping rules of nucelos (t) ide analog (NA) treatment for
chronic hepatitis B (CHB). Methods A total of 113 consecutive patients with CHB (45 HBeAg …

Viral hepatitis is a significant health problem worldwide, associated with morbidity and
mortality. Hepatitis B, C, D, and occasionally E viruses (HBV, HCV, HDV, and HEV) can …

Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a
threat to public health due to its high morbidity and disease-related mortality. Since the latest …

Abstract Background Hepatitis B virus (HBV) has a long history in human infectious
diseases. HBV infection can progress chronically, leading to cancer. After introduction of a …

Chronic hepatitis B virus (HBV) infection is a worldwide public health threat that results in
huge morbidity and mortality. Late diagnosis and delayed treatment of HBV infections can …